Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Head-to-head comparison of Kisspeptin-10 and Oxytocin — mechanism, side effects, legal status, and pricing.
Kisspeptin-10 (KP-10) is the 10-amino-acid C-terminal fragment of kisspeptin (the KISS1 gene product, also called metastin) that retains full biological activity. It is an investigational signaling peptide that sits at the top of the reproductive axis and is studied for fertility, hypogonadism, and as a diagnostic challenge. It is not FDA-approved.
Oxytocin is a nine-amino acid peptide hormone (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, with a disulfide bridge between Cys1 and Cys6) produced in the hypothalamic paraventricular and supraoptic nuclei. The synthetic form (Pitocin) is FDA-approved as IV/IM injection for labor induction/augmentation and postpartum hemorrhage control. Intranasal oxytocin is NOT FDA-approved and is used off-label or in research settings for social/behavioral indications, where evidence is mixed.
Kisspeptin-10
Oxytocin
Category
Legal Status
Mechanism
Half-life
Side Effects
COA-verified vendors · trust score ≥70 required · single-vial price — bulk/bundle deals may be lower
Kisspeptin-10
Oxytocin
COA corpus from Disclosed Labs — independently tested batches only.
Kisspeptin-10
50
COAs
99.6%
Avg purity
11
Labs
Oxytocin
32
COAs
99.0%
Avg purity
9
Labs
The foundational role of kisspeptin in reproduction was established by de Roux et al. (PNAS, 2003, PMID 12944565) and Seminara et al. (NEJM, 2003, PMID 14573733), who identified loss-of-function mutations in GPR54 causing hypogonadotropic hypogonadism. Dhillo et al. (JCEM, 2005) showed kisspeptin-54 stimulates LH, FSH, and testosterone in men; George et al. (JCEM, 2011, PMID 21632807) confirmed IV kisspeptin-10 boluses stimulate LH and increase pulse frequency in men. Young et al. (Neuroendocrinology, 2012, PMID 22377698) showed kisspeptin infusion restores pulsatile LH in patients with neurokinin B (TAC3/TACR3) signaling deficiencies. Abbara/Jayasena and colleagues (JCEM 2015, PMID 26192876; Hum Reprod 2017, PMID 28854728) demonstrated kisspeptin-54 can trigger oocyte maturation in IVF with very low OHSS rates. The kisspeptin receptor agonist MVT-602 has been in Phase 2 development for female HSDD. Grey-market SubQ use (~200 mcg 2x/week for libido or testosterone support) is not supported by controlled trials.
Key references
Pitocin has decades of obstetric use under its FDA label. Intranasal oxytocin has been studied in dozens of RCTs across autism, social anxiety, PTSD, and schizophrenia. Evidence is MIXED and frequently negative for larger/more rigorous trials. Sikich et al. 2021 (NEJM, SOARS-B, PMID 34644471) — the largest placebo-controlled RCT (N=290) of intranasal oxytocin for autism — found no significant benefit over placebo on social or cognitive functioning over 24 weeks. Ooi et al. 2017 meta-analysis (PMID 27574858) found no significant overall effect of oxytocin on social cognition or repetitive behaviors in ASD. Leng & Ludwig 2016 'Intranasal Oxytocin: Myths and Delusions' (Biological Psychiatry, PMID 26049207) estimate <0.005% of intranasal dose reaches CSF, questioning the pharmacologic basis for reported behavioral effects. Marketing of intranasal oxytocin as a 'love/bonding' compound is not supported by the strongest clinical evidence. Pitocin FDA label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018261s031lbl.pdf
Kisspeptin-10 and Oxytocin are both in the Hormone category and may have overlapping mechanisms. Researchers should review both profiles carefully, understand the mechanisms of action, and monitor the relevant biomarkers when combining compounds in the same class. As always, consult a licensed healthcare provider before making any decisions about combining research compounds.
This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.
Contraindications
Lab Testing
Key references